rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
5
|
pubmed:dateCreated |
2009-12-2
|
pubmed:databankReference |
|
pubmed:abstractText |
The Increased Flow Utilizing Subcutaneously-Enabled (INFUSE)-Pediatric Rehydration Study was designed to assess efficacy, safety, and clinical utility of recombinant human hyaluronidase (rHuPH20)-facilitated subcutaneous rehydration in children 2 months to 10 years of age.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
1098-4275
|
pubmed:author |
pubmed-author:AllenCoburn HCH,
pubmed-author:EtzwilerLisa SLS,
pubmed-author:HahnBarryB,
pubmed-author:HarbGeorgeG,
pubmed-author:HostetlerMark AMA,
pubmed-author:MaceSharonS,
pubmed-author:MaherGeorgeG,
pubmed-author:MillerMelissa KMK,
pubmed-author:ReinhardtNeilN,
pubmed-author:SmithSharon RSR,
pubmed-author:Turtle Creek Conference II
|
pubmed:issnType |
Electronic
|
pubmed:volume |
124
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
e858-67
|
pubmed:meshHeading |
pubmed-meshheading:19805455-Child,
pubmed-meshheading:19805455-Child, Preschool,
pubmed-meshheading:19805455-Dehydration,
pubmed-meshheading:19805455-Female,
pubmed-meshheading:19805455-Humans,
pubmed-meshheading:19805455-Hyaluronoglucosaminidase,
pubmed-meshheading:19805455-Infant,
pubmed-meshheading:19805455-Infusion Pumps,
pubmed-meshheading:19805455-Infusions, Subcutaneous,
pubmed-meshheading:19805455-Injections, Subcutaneous,
pubmed-meshheading:19805455-Male,
pubmed-meshheading:19805455-Recombinant Proteins,
pubmed-meshheading:19805455-Rehydration Solutions
|
pubmed:year |
2009
|
pubmed:articleTitle |
Recombinant human hyaluronidase-enabled subcutaneous pediatric rehydration.
|
pubmed:affiliation |
Section of Emergency Medicine,Department of Pediatrics, Baylor College of Medicine and Texas Children's Hospital, Houston, Texas 77030, USA. challen@texaschildrenshospital.org
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Multicenter Study,
Clinical Trial, Phase IV
|